Nuvation Bio Inc. (NUVB) Return on Equity (ROE) and Return on Assets (ROA)

Nuvation Bio Inc. (NUVB) return on equity (ROE) and return on assets (ROA) history. Calculate ROE/ROA in Excel with MarketXLS.

ROE & ROA Data

PeriodROEROA
2020-12-31-19.37%-18.78%
2021-12-31-11.64%-11.19%
2022-12-31-15.91%-15.50%
2023-12-31-12.53%-12.20%
2024-12-31-122.46%-105.05%
2025-12-31-66.93%-34.40%

Return on equity divides net income by total shareholder equity at the period end. Return on assets divides the same net income by total assets at the period end. A figure reads N/A when the divisor is missing or not positive, because the ratio is not meaningful then.

How NUVB compares with sector peers

SymbolCompanyReturn on equity (latest fiscal year)
ICUIICU Medical Inc.0.03%
TXMDTherapeuticsMD Inc.-2.12%
ARRYArray Technologies Inc.-20.06%
VTRSViatris Inc.-23.89%
PMCBPharmaCyte Biotech Inc.-55.53%

These are five companies in the same sector as NUVB with a comparable annual return on equity. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.

Get Nuvation Bio Inc. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

Try: =hf_Return_on_Average_Equity("NUVB", 2024)

BUY NOW